Date: August 24, 2026
Regulatory Compliance Update
US FDA Inspection Details
- The United States Food and Drug Administration (US FDA) conducted a routine inspection at Lannett Company LLC
- Lannett Company LLC is a wholly owned step-down subsidiary of Aurobindo Pharma Limited through Aurobindo Pharma USA, Inc.
- Inspection location: Seymour, IN, USA
- Inspection period: August 17 to August 21, 2026
Inspection Outcome
- The inspection concluded with four observations
- All observations are described as procedural in nature
- Company will respond to US FDA within the stipulated timeline
Company Commitment
- Company committed to maintaining robust quality and compliance standards across its manufacturing facilities
- Company will keep stock exchanges informed of any further developments as required under applicable regulations
Regulatory Framework
- Disclosure made pursuant to Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015
- Signed by B. Adi Reddy, Company Secretary, on August 24, 2026 at 08:48:06 IST